Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |